https://www.selleckchem.com/products/k03861.html
In patients with endometrial cancer, obesity is associated with favorable prognostic characteristics but not with prolonged survival. The aim of this study was to elucidate the reason for this clinical paradox. We retrospectively reviewed 1173 patients with endometrial cancer. Patients were divided into a non-obese group [body mass index (BMI)30kg/m2], class I obesity group (BMI 30-35kg/m2) and class II obesity group (BMI≥35kg/m2). The relationship between clinicopathological factors and disease-specific survival (DSS) was analyzed b